nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—ADRA2A—type 2 diabetes mellitus	0.172	0.412	CbGaD
Dexmedetomidine—CYP2E1—type 2 diabetes mellitus	0.126	0.301	CbGaD
Dexmedetomidine—CYP1A2—type 2 diabetes mellitus	0.12	0.286	CbGaD
Dexmedetomidine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0587	0.165	CbGbCtD
Dexmedetomidine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0533	0.149	CbGbCtD
Dexmedetomidine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0505	0.142	CbGbCtD
Dexmedetomidine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0427	0.12	CbGbCtD
Dexmedetomidine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0352	0.0986	CbGbCtD
Dexmedetomidine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0191	0.0535	CbGbCtD
Dexmedetomidine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.017	0.0477	CbGbCtD
Dexmedetomidine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0157	0.0441	CbGbCtD
Dexmedetomidine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.015	0.0421	CbGbCtD
Dexmedetomidine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0142	0.0398	CbGbCtD
Dexmedetomidine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0129	0.0362	CbGbCtD
Dexmedetomidine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0124	0.0347	CbGbCtD
Dexmedetomidine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00967	0.0271	CbGbCtD
Dexmedetomidine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00175	0.222	CbGeAlD
Dexmedetomidine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00117	0.149	CbGeAlD
Dexmedetomidine—SLC6A2—nerve—type 2 diabetes mellitus	0.00066	0.084	CbGeAlD
Dexmedetomidine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000598	0.0762	CbGeAlD
Dexmedetomidine—ADRA1B—kidney—type 2 diabetes mellitus	0.000374	0.0476	CbGeAlD
Dexmedetomidine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000228	0.029	CbGeAlD
Dexmedetomidine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000226	0.0288	CbGeAlD
Dexmedetomidine—ADRA2C—kidney—type 2 diabetes mellitus	0.0002	0.0255	CbGeAlD
Dexmedetomidine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000199	0.0253	CbGeAlD
Dexmedetomidine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000195	0.0248	CbGeAlD
Dexmedetomidine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000181	0.023	CbGeAlD
Dexmedetomidine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000178	0.0227	CbGeAlD
Dexmedetomidine—CYP1A1—kidney—type 2 diabetes mellitus	0.000171	0.0218	CbGeAlD
Dexmedetomidine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.00016	0.0203	CbGeAlD
Dexmedetomidine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000159	0.0202	CbGeAlD
Dexmedetomidine—CYP2E1—kidney—type 2 diabetes mellitus	0.000156	0.0199	CbGeAlD
Dexmedetomidine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000156	0.0198	CbGeAlD
Dexmedetomidine—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000155	0.0197	CbGeAlD
Dexmedetomidine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000154	0.00116	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000153	0.00115	CcSEcCtD
Dexmedetomidine—Rash—Repaglinide—type 2 diabetes mellitus	0.000153	0.00115	CcSEcCtD
Dexmedetomidine—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000153	0.00115	CcSEcCtD
Dexmedetomidine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000153	0.00115	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000153	0.00115	CcSEcCtD
Dexmedetomidine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000152	0.0194	CbGeAlD
Dexmedetomidine—Headache—Repaglinide—type 2 diabetes mellitus	0.000152	0.00114	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000152	0.00114	CcSEcCtD
Dexmedetomidine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000152	0.00114	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000152	0.00114	CcSEcCtD
Dexmedetomidine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000152	0.00114	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000152	0.00114	CcSEcCtD
Dexmedetomidine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00113	CcSEcCtD
Dexmedetomidine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00113	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00015	0.00112	CcSEcCtD
Dexmedetomidine—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000149	0.00112	CcSEcCtD
Dexmedetomidine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000148	0.00112	CcSEcCtD
Dexmedetomidine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000148	0.00111	CcSEcCtD
Dexmedetomidine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000148	0.00111	CcSEcCtD
Dexmedetomidine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000148	0.00111	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000147	0.00111	CcSEcCtD
Dexmedetomidine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000147	0.0011	CcSEcCtD
Dexmedetomidine—Chills—Metformin—type 2 diabetes mellitus	0.000147	0.0011	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000146	0.0011	CcSEcCtD
Dexmedetomidine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000145	0.00109	CcSEcCtD
Dexmedetomidine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00109	CcSEcCtD
Dexmedetomidine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000145	0.00109	CcSEcCtD
Dexmedetomidine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000145	0.00109	CcSEcCtD
Dexmedetomidine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000144	0.00108	CcSEcCtD
Dexmedetomidine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000144	0.00108	CcSEcCtD
Dexmedetomidine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000144	0.0183	CbGeAlD
Dexmedetomidine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000144	0.00108	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000143	0.00108	CcSEcCtD
Dexmedetomidine—Malnutrition—Metformin—type 2 diabetes mellitus	0.000142	0.00107	CcSEcCtD
Dexmedetomidine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000142	0.00106	CcSEcCtD
Dexmedetomidine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00014	0.00105	CcSEcCtD
Dexmedetomidine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00014	0.00105	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000139	0.00105	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000139	0.00105	CcSEcCtD
Dexmedetomidine—Chills—Irbesartan—type 2 diabetes mellitus	0.000139	0.00104	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00104	CcSEcCtD
Dexmedetomidine—Infection—Gliclazide—type 2 diabetes mellitus	0.000138	0.00104	CcSEcCtD
Dexmedetomidine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000138	0.00104	CcSEcCtD
Dexmedetomidine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000138	0.00104	CcSEcCtD
Dexmedetomidine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000138	0.00103	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000137	0.00103	CcSEcCtD
Dexmedetomidine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000136	0.00102	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000136	0.00102	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000136	0.00102	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000136	0.00102	CcSEcCtD
Dexmedetomidine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000136	0.00102	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000135	0.00101	CcSEcCtD
Dexmedetomidine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000134	0.00101	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000134	0.00101	CcSEcCtD
Dexmedetomidine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000134	0.00101	CcSEcCtD
Dexmedetomidine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00101	CcSEcCtD
Dexmedetomidine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00101	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000134	0.001	CcSEcCtD
Dexmedetomidine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000133	0.000999	CcSEcCtD
Dexmedetomidine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000133	0.000997	CcSEcCtD
Dexmedetomidine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000132	0.00099	CcSEcCtD
Dexmedetomidine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000132	0.00099	CcSEcCtD
Dexmedetomidine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000131	0.000985	CcSEcCtD
Dexmedetomidine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00013	0.000978	CcSEcCtD
Dexmedetomidine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00013	0.000975	CcSEcCtD
Dexmedetomidine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00013	0.000975	CcSEcCtD
Dexmedetomidine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000129	0.000967	CcSEcCtD
Dexmedetomidine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000128	0.000964	CcSEcCtD
Dexmedetomidine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000128	0.000961	CcSEcCtD
Dexmedetomidine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000128	0.00096	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000128	0.000958	CcSEcCtD
Dexmedetomidine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000127	0.000957	CcSEcCtD
Dexmedetomidine—Infection—Valsartan—type 2 diabetes mellitus	0.000127	0.000953	CcSEcCtD
Dexmedetomidine—Rash—Glipizide—type 2 diabetes mellitus	0.000127	0.000952	CcSEcCtD
Dexmedetomidine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000127	0.000951	CcSEcCtD
Dexmedetomidine—ADRA2C—liver—type 2 diabetes mellitus	0.000127	0.0161	CbGeAlD
Dexmedetomidine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000127	0.00095	CcSEcCtD
Dexmedetomidine—Headache—Glipizide—type 2 diabetes mellitus	0.000126	0.000946	CcSEcCtD
Dexmedetomidine—Infection—Orlistat—type 2 diabetes mellitus	0.000125	0.000941	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000125	0.000939	CcSEcCtD
Dexmedetomidine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000933	CcSEcCtD
Dexmedetomidine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000124	0.000932	CcSEcCtD
Dexmedetomidine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000124	0.00093	CcSEcCtD
Dexmedetomidine—CYP2D6—kidney—type 2 diabetes mellitus	0.000124	0.0158	CbGeAlD
Dexmedetomidine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000124	0.000929	CcSEcCtD
Dexmedetomidine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000124	0.000928	CcSEcCtD
Dexmedetomidine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000124	0.000928	CcSEcCtD
Dexmedetomidine—Hypertension—Metformin—type 2 diabetes mellitus	0.000123	0.000924	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000123	0.000922	CcSEcCtD
Dexmedetomidine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000122	0.000919	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000122	0.000916	CcSEcCtD
Dexmedetomidine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000121	0.000906	CcSEcCtD
Dexmedetomidine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.00012	0.000902	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00012	0.000901	CcSEcCtD
Dexmedetomidine—Nausea—Glipizide—type 2 diabetes mellitus	0.000119	0.000897	CcSEcCtD
Dexmedetomidine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000119	0.000896	CcSEcCtD
Dexmedetomidine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000119	0.000896	CcSEcCtD
Dexmedetomidine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000119	0.000893	CcSEcCtD
Dexmedetomidine—Pain—Gliclazide—type 2 diabetes mellitus	0.000119	0.000892	CcSEcCtD
Dexmedetomidine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000119	0.000892	CcSEcCtD
Dexmedetomidine—Rash—Glimepiride—type 2 diabetes mellitus	0.000118	0.000889	CcSEcCtD
Dexmedetomidine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000118	0.000888	CcSEcCtD
Dexmedetomidine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000118	0.000886	CcSEcCtD
Dexmedetomidine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000118	0.000885	CcSEcCtD
Dexmedetomidine—Headache—Glimepiride—type 2 diabetes mellitus	0.000118	0.000883	CcSEcCtD
Dexmedetomidine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000117	0.00088	CcSEcCtD
Dexmedetomidine—Anaemia—Losartan—type 2 diabetes mellitus	0.000117	0.000878	CcSEcCtD
Dexmedetomidine—Agitation—Losartan—type 2 diabetes mellitus	0.000116	0.000873	CcSEcCtD
Dexmedetomidine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000116	0.000872	CcSEcCtD
Dexmedetomidine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00087	CcSEcCtD
Dexmedetomidine—Infection—Metformin—type 2 diabetes mellitus	0.000115	0.000867	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000115	0.00086	CcSEcCtD
Dexmedetomidine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000114	0.000857	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000114	0.000855	CcSEcCtD
Dexmedetomidine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000114	0.000855	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000114	0.000853	CcSEcCtD
Dexmedetomidine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000113	0.000852	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000112	0.000844	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000112	0.000843	CcSEcCtD
Dexmedetomidine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000841	CcSEcCtD
Dexmedetomidine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000112	0.000841	CcSEcCtD
Dexmedetomidine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000111	0.000837	CcSEcCtD
Dexmedetomidine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000111	0.000836	CcSEcCtD
Dexmedetomidine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000111	0.000834	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00011	0.000828	CcSEcCtD
Dexmedetomidine—CYP1A2—liver—type 2 diabetes mellitus	0.00011	0.014	CbGeAlD
Dexmedetomidine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00011	0.000825	CcSEcCtD
Dexmedetomidine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00011	0.000825	CcSEcCtD
Dexmedetomidine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.00082	CcSEcCtD
Dexmedetomidine—Constipation—Valsartan—type 2 diabetes mellitus	0.000109	0.00082	CcSEcCtD
Dexmedetomidine—Infection—Irbesartan—type 2 diabetes mellitus	0.000109	0.000819	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000109	0.000818	CcSEcCtD
Dexmedetomidine—Hypotension—Metformin—type 2 diabetes mellitus	0.000109	0.000816	CcSEcCtD
Dexmedetomidine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000108	0.000815	CcSEcCtD
Dexmedetomidine—CYP1A1—liver—type 2 diabetes mellitus	0.000108	0.0138	CbGeAlD
Dexmedetomidine—Pain—Orlistat—type 2 diabetes mellitus	0.000108	0.00081	CcSEcCtD
Dexmedetomidine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000808	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000807	CcSEcCtD
Dexmedetomidine—Anxiety—Losartan—type 2 diabetes mellitus	0.000107	0.000806	CcSEcCtD
Dexmedetomidine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000804	CcSEcCtD
Dexmedetomidine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000802	CcSEcCtD
Dexmedetomidine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000801	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000106	0.000797	CcSEcCtD
Dexmedetomidine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000796	CcSEcCtD
Dexmedetomidine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000106	0.000795	CcSEcCtD
Dexmedetomidine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000105	0.000791	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000104	0.000784	CcSEcCtD
Dexmedetomidine—Confusional state—Losartan—type 2 diabetes mellitus	0.000104	0.000782	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000104	0.000781	CcSEcCtD
Dexmedetomidine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000104	0.000778	CcSEcCtD
Dexmedetomidine—Somnolence—Metformin—type 2 diabetes mellitus	0.000103	0.000776	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000103	0.000775	CcSEcCtD
Dexmedetomidine—Infection—Losartan—type 2 diabetes mellitus	0.000103	0.00077	CcSEcCtD
Dexmedetomidine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000103	0.00077	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000101	0.000759	CcSEcCtD
Dexmedetomidine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000101	0.000758	CcSEcCtD
Dexmedetomidine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000101	0.000757	CcSEcCtD
Dexmedetomidine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000101	0.000755	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.0001	0.000754	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.98e-05	0.00075	CcSEcCtD
Dexmedetomidine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000749	CcSEcCtD
Dexmedetomidine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000749	CcSEcCtD
Dexmedetomidine—Agitation—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000749	CcSEcCtD
Dexmedetomidine—Constipation—Metformin—type 2 diabetes mellitus	9.94e-05	0.000747	CcSEcCtD
Dexmedetomidine—CYP2E1—liver—type 2 diabetes mellitus	9.89e-05	0.0126	CbGeAlD
Dexmedetomidine—Vomiting—Glyburide—type 2 diabetes mellitus	9.84e-05	0.000739	CcSEcCtD
Dexmedetomidine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.78e-05	0.000735	CcSEcCtD
Dexmedetomidine—Rash—Glyburide—type 2 diabetes mellitus	9.76e-05	0.000733	CcSEcCtD
Dexmedetomidine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.75e-05	0.000733	CcSEcCtD
Dexmedetomidine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.75e-05	0.000732	CcSEcCtD
Dexmedetomidine—Headache—Glyburide—type 2 diabetes mellitus	9.69e-05	0.000728	CcSEcCtD
Dexmedetomidine—Hypotension—Losartan—type 2 diabetes mellitus	9.65e-05	0.000725	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.58e-05	0.00072	CcSEcCtD
Dexmedetomidine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.51e-05	0.000714	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.51e-05	0.000714	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.47e-05	0.000711	CcSEcCtD
Dexmedetomidine—Convulsion—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000706	CcSEcCtD
Dexmedetomidine—Pain—Irbesartan—type 2 diabetes mellitus	9.38e-05	0.000705	CcSEcCtD
Dexmedetomidine—Constipation—Irbesartan—type 2 diabetes mellitus	9.38e-05	0.000705	CcSEcCtD
Dexmedetomidine—Dyspnoea—Losartan—type 2 diabetes mellitus	9.21e-05	0.000691	CcSEcCtD
Dexmedetomidine—Anxiety—Ramipril—type 2 diabetes mellitus	9.2e-05	0.000691	CcSEcCtD
Dexmedetomidine—Nausea—Glyburide—type 2 diabetes mellitus	9.19e-05	0.00069	CcSEcCtD
Dexmedetomidine—Abdominal pain—Metformin—type 2 diabetes mellitus	9.19e-05	0.00069	CcSEcCtD
Dexmedetomidine—Dizziness—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.00069	CcSEcCtD
Dexmedetomidine—Somnolence—Losartan—type 2 diabetes mellitus	9.18e-05	0.000689	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.04e-05	0.000679	CcSEcCtD
Dexmedetomidine—Dry mouth—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000678	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.97e-05	0.000674	CcSEcCtD
Dexmedetomidine—Confusional state—Ramipril—type 2 diabetes mellitus	8.93e-05	0.00067	CcSEcCtD
Dexmedetomidine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.83e-05	0.000664	CcSEcCtD
Dexmedetomidine—Pain—Losartan—type 2 diabetes mellitus	8.83e-05	0.000663	CcSEcCtD
Dexmedetomidine—Constipation—Losartan—type 2 diabetes mellitus	8.83e-05	0.000663	CcSEcCtD
Dexmedetomidine—Rash—Gliclazide—type 2 diabetes mellitus	8.76e-05	0.000658	CcSEcCtD
Dexmedetomidine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.75e-05	0.000657	CcSEcCtD
Dexmedetomidine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.73e-05	0.000656	CcSEcCtD
Dexmedetomidine—Headache—Gliclazide—type 2 diabetes mellitus	8.7e-05	0.000654	CcSEcCtD
Dexmedetomidine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000651	CcSEcCtD
Dexmedetomidine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000651	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000651	CcSEcCtD
Dexmedetomidine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000649	CcSEcCtD
Dexmedetomidine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.63e-05	0.000648	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000643	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.51e-05	0.000639	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.44e-05	0.000634	CcSEcCtD
Dexmedetomidine—Dizziness—Valsartan—type 2 diabetes mellitus	8.44e-05	0.000634	CcSEcCtD
Dexmedetomidine—Dizziness—Orlistat—type 2 diabetes mellitus	8.34e-05	0.000627	CcSEcCtD
Dexmedetomidine—Hypotension—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000621	CcSEcCtD
Dexmedetomidine—Nausea—Gliclazide—type 2 diabetes mellitus	8.25e-05	0.00062	CcSEcCtD
Dexmedetomidine—Abdominal pain—Losartan—type 2 diabetes mellitus	8.16e-05	0.000613	CcSEcCtD
Dexmedetomidine—Body temperature increased—Losartan—type 2 diabetes mellitus	8.16e-05	0.000613	CcSEcCtD
Dexmedetomidine—Vomiting—Valsartan—type 2 diabetes mellitus	8.12e-05	0.00061	CcSEcCtD
Dexmedetomidine—Rash—Valsartan—type 2 diabetes mellitus	8.05e-05	0.000605	CcSEcCtD
Dexmedetomidine—Dermatitis—Valsartan—type 2 diabetes mellitus	8.04e-05	0.000604	CcSEcCtD
Dexmedetomidine—Vomiting—Orlistat—type 2 diabetes mellitus	8.02e-05	0.000602	CcSEcCtD
Dexmedetomidine—Headache—Valsartan—type 2 diabetes mellitus	8e-05	0.000601	CcSEcCtD
Dexmedetomidine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.95e-05	0.000597	CcSEcCtD
Dexmedetomidine—Rash—Orlistat—type 2 diabetes mellitus	7.95e-05	0.000597	CcSEcCtD
Dexmedetomidine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.95e-05	0.000597	CcSEcCtD
Dexmedetomidine—Headache—Orlistat—type 2 diabetes mellitus	7.9e-05	0.000594	CcSEcCtD
Dexmedetomidine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000593	CcSEcCtD
Dexmedetomidine—Somnolence—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000591	CcSEcCtD
Dexmedetomidine—CYP2D6—liver—type 2 diabetes mellitus	7.83e-05	0.00996	CbGeAlD
Dexmedetomidine—Dizziness—Metformin—type 2 diabetes mellitus	7.69e-05	0.000577	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000574	CcSEcCtD
Dexmedetomidine—Nausea—Valsartan—type 2 diabetes mellitus	7.58e-05	0.00057	CcSEcCtD
Dexmedetomidine—Constipation—Ramipril—type 2 diabetes mellitus	7.57e-05	0.000569	CcSEcCtD
Dexmedetomidine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000564	CcSEcCtD
Dexmedetomidine—Nausea—Orlistat—type 2 diabetes mellitus	7.49e-05	0.000563	CcSEcCtD
Dexmedetomidine—Vomiting—Metformin—type 2 diabetes mellitus	7.39e-05	0.000555	CcSEcCtD
Dexmedetomidine—Rash—Metformin—type 2 diabetes mellitus	7.33e-05	0.000551	CcSEcCtD
Dexmedetomidine—Dermatitis—Metformin—type 2 diabetes mellitus	7.32e-05	0.00055	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000548	CcSEcCtD
Dexmedetomidine—Headache—Metformin—type 2 diabetes mellitus	7.28e-05	0.000547	CcSEcCtD
Dexmedetomidine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000545	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000544	CcSEcCtD
Dexmedetomidine—Diarrhoea—Losartan—type 2 diabetes mellitus	7.06e-05	0.000531	CcSEcCtD
Dexmedetomidine—Body temperature increased—Ramipril—type 2 diabetes mellitus	7e-05	0.000526	CcSEcCtD
Dexmedetomidine—Abdominal pain—Ramipril—type 2 diabetes mellitus	7e-05	0.000526	CcSEcCtD
Dexmedetomidine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000524	CcSEcCtD
Dexmedetomidine—Rash—Irbesartan—type 2 diabetes mellitus	6.92e-05	0.00052	CcSEcCtD
Dexmedetomidine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.000519	CcSEcCtD
Dexmedetomidine—Nausea—Metformin—type 2 diabetes mellitus	6.91e-05	0.000519	CcSEcCtD
Dexmedetomidine—Headache—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000516	CcSEcCtD
Dexmedetomidine—Dizziness—Losartan—type 2 diabetes mellitus	6.83e-05	0.000513	CcSEcCtD
Dexmedetomidine—Vomiting—Losartan—type 2 diabetes mellitus	6.56e-05	0.000493	CcSEcCtD
Dexmedetomidine—Nausea—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000489	CcSEcCtD
Dexmedetomidine—Rash—Losartan—type 2 diabetes mellitus	6.51e-05	0.000489	CcSEcCtD
Dexmedetomidine—Dermatitis—Losartan—type 2 diabetes mellitus	6.5e-05	0.000488	CcSEcCtD
Dexmedetomidine—Headache—Losartan—type 2 diabetes mellitus	6.47e-05	0.000486	CcSEcCtD
Dexmedetomidine—Nausea—Losartan—type 2 diabetes mellitus	6.13e-05	0.000461	CcSEcCtD
Dexmedetomidine—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000455	CcSEcCtD
Dexmedetomidine—Dizziness—Ramipril—type 2 diabetes mellitus	5.85e-05	0.00044	CcSEcCtD
Dexmedetomidine—Vomiting—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000423	CcSEcCtD
Dexmedetomidine—Rash—Ramipril—type 2 diabetes mellitus	5.58e-05	0.000419	CcSEcCtD
Dexmedetomidine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.58e-05	0.000419	CcSEcCtD
Dexmedetomidine—Headache—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000417	CcSEcCtD
Dexmedetomidine—Nausea—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000395	CcSEcCtD
Dexmedetomidine—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.14e-06	4.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	4.14e-06	4.88e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.13e-06	4.88e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.13e-06	4.88e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.13e-06	4.88e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	4.13e-06	4.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—LEP—type 2 diabetes mellitus	4.12e-06	4.86e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—APOE—type 2 diabetes mellitus	4.12e-06	4.86e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.11e-06	4.85e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.11e-06	4.85e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.11e-06	4.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	4.08e-06	4.82e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.07e-06	4.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.07e-06	4.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	4.05e-06	4.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	4.05e-06	4.78e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	4.05e-06	4.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.04e-06	4.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.03e-06	4.76e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.03e-06	4.76e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	4.03e-06	4.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.02e-06	4.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	4.02e-06	4.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.01e-06	4.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	4e-06	4.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	3.99e-06	4.71e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.96e-06	4.68e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.96e-06	4.68e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	3.96e-06	4.66e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.95e-06	4.65e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.93e-06	4.64e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	3.93e-06	4.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.91e-06	4.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.88e-06	4.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.88e-06	4.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.88e-06	4.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.87e-06	4.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.87e-06	4.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.87e-06	4.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.87e-06	4.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ALB—type 2 diabetes mellitus	3.86e-06	4.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.83e-06	4.52e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.82e-06	4.51e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.8e-06	4.48e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.77e-06	4.44e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	3.77e-06	4.44e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.75e-06	4.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.74e-06	4.42e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	3.72e-06	4.39e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.72e-06	4.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.71e-06	4.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PIK3R1—type 2 diabetes mellitus	3.69e-06	4.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—NOS3—type 2 diabetes mellitus	3.69e-06	4.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.69e-06	4.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.69e-06	4.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.68e-06	4.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.67e-06	4.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.67e-06	4.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.66e-06	4.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.66e-06	4.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	3.65e-06	4.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.64e-06	4.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.64e-06	4.29e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.63e-06	4.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.63e-06	4.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.62e-06	4.27e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	3.59e-06	4.24e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.54e-06	4.18e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	3.54e-06	4.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—INS—type 2 diabetes mellitus	3.52e-06	4.15e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.5e-06	4.13e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	3.48e-06	4.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	3.48e-06	4.1e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	3.46e-06	4.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	3.46e-06	4.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.46e-06	4.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.46e-06	4.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	3.44e-06	4.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.43e-06	4.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	3.42e-06	4.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.42e-06	4.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	3.42e-06	4.03e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.42e-06	4.03e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.42e-06	4.03e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.42e-06	4.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.41e-06	4.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.41e-06	4.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.4e-06	4.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.4e-06	4.01e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.4e-06	4.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	3.4e-06	4.01e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.4e-06	4.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.39e-06	3.99e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	3.38e-06	3.98e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.36e-06	3.96e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.36e-06	3.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.36e-06	3.96e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.36e-06	3.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.35e-06	3.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.35e-06	3.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.35e-06	3.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.35e-06	3.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.33e-06	3.93e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.31e-06	3.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.3e-06	3.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.3e-06	3.9e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.26e-06	3.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.23e-06	3.81e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.2e-06	3.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.18e-06	3.75e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.17e-06	3.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.15e-06	3.72e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.14e-06	3.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.14e-06	3.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	3.13e-06	3.7e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.11e-06	3.67e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.11e-06	3.67e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.11e-06	3.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.09e-06	3.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.09e-06	3.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.09e-06	3.64e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.04e-06	3.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.04e-06	3.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.04e-06	3.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.03e-06	3.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	3.02e-06	3.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	3e-06	3.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	3e-06	3.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.98e-06	3.52e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.96e-06	3.49e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.96e-06	3.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.94e-06	3.46e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.92e-06	3.44e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.9e-06	3.43e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.9e-06	3.43e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.89e-06	3.41e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.89e-06	3.41e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.88e-06	3.4e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.88e-06	3.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.86e-06	3.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.86e-06	3.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.85e-06	3.36e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.84e-06	3.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.83e-06	3.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.81e-06	3.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.8e-06	3.31e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.8e-06	3.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.79e-06	3.29e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.76e-06	3.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.76e-06	3.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.76e-06	3.25e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.75e-06	3.25e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.75e-06	3.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.75e-06	3.24e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.75e-06	3.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	2.74e-06	3.23e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	2.71e-06	3.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	2.71e-06	3.19e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.68e-06	3.17e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.66e-06	3.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.65e-06	3.13e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.64e-06	3.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.64e-06	3.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.63e-06	3.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.63e-06	3.1e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.62e-06	3.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.62e-06	3.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-06	3.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.61e-06	3.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.6e-06	3.07e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.6e-06	3.07e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.6e-06	3.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.6e-06	3.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.58e-06	3.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.58e-06	3.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-06	3.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.57e-06	3.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.57e-06	3.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.56e-06	3.02e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.52e-06	2.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.51e-06	2.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.51e-06	2.96e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.5e-06	2.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.48e-06	2.92e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.47e-06	2.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.45e-06	2.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.44e-06	2.88e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.44e-06	2.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.42e-06	2.85e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.41e-06	2.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.4e-06	2.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.38e-06	2.81e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.37e-06	2.8e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.37e-06	2.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.37e-06	2.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.36e-06	2.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.36e-06	2.78e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.33e-06	2.75e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.28e-06	2.69e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.27e-06	2.68e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.25e-06	2.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.25e-06	2.65e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.23e-06	2.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.22e-06	2.62e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.22e-06	2.61e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.21e-06	2.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.19e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.18e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.18e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.15e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.14e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.13e-06	2.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.11e-06	2.49e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.04e-06	2.41e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.04e-06	2.41e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.01e-06	2.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.01e-06	2.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	2e-06	2.36e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.99e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.97e-06	2.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.95e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.95e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.95e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.92e-06	2.27e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.89e-06	2.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.85e-06	2.19e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.82e-06	2.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.81e-06	2.13e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	2.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.73e-06	2.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	1.7e-06	2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.68e-06	1.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.66e-06	1.95e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.65e-06	1.95e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.65e-06	1.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.65e-06	1.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.62e-06	1.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.54e-06	1.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.52e-06	1.79e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.51e-06	1.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.51e-06	1.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.42e-06	1.67e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.4e-06	1.65e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	1.38e-06	1.63e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-06	1.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.25e-06	1.47e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.41e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.15e-06	1.36e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.98e-07	1.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.61e-07	8.97e-06	CbGpPWpGaD
